Reductions in IHL have been repeatedly related to GH/IGF-I axis activity in individuals both without (17) and with acromegaly (18, 19), and a decrease in IHL was also reported in obese patients after 6 months of GH administration (20). The gene discussed is GH1; the disease is acromegaly.